Study S001172

Exercise and Nutritional Intervention to Reduce the Risk of Sarcopenia in Older Adults With Type 2 Diabetes and Obesity Treated With Semaglutide: A Randomized Controlled Trial

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06497595
Acronym: STAY-STRONG
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: SINGLE
Status: RECRUITING
Enrollment: 60
Start: 2025-05-11
Primary completion: 2027-09-30
Lead sponsor: Sheba Medical Center
Conditions: Type 2 Diabetes Mellitus in Obese
Interventions: BEHAVIORAL:Wegovy (2.4 Mg Dose) + exercise & nutrition; OTHER:Wegovy (2.4 Mg Dose) + usual care
Results posted: FALSE

Registered primary outcomes

Thigh muscle volume (TMV) [26 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.